What the science actually says about mushrooms and health

The term "shrooms" usually refers to psilocybin mushrooms — fungi that contain psychoactive compounds — but it can also mean medicinal mushrooms like lion's mane, reishi, or cordyceps. The research picture is very different between the two. Psilocybin has shown measurable effects in clinical trials for depression and end-of-life anxiety, but it remains a controlled substance in most places and is not yet approved by the FDA as a standard treatment. Medicinal mushrooms have a longer history of use in traditional medicine, though the human evidence for most is still limited compared to the animal studies and lab work that exist.

This guide explains what peer-reviewed research has found so far, what the limitations are, and where the evidence is still emerging. It is not medical information and does not replace a conversation with a doctor.

Key Takeaways

  • Psilocybin has shown promise in clinical trials for treatment-resistant depression and anxiety in people facing terminal illness, but remains illegal in most jurisdictions and is not yet an FDA-approved medication.
  • Medicinal mushrooms like lion's mane and reishi have been used in traditional medicine for centuries, but most lack large-scale human trials; the evidence is stronger for some compounds than others.
  • The difference between psilocybin research and medicinal mushroom research is significant — one involves controlled clinical settings and FDA oversight, the other often relies on smaller studies or animal models.
  • Mushroom supplements are not regulated the same way as pharmaceuticals, so potency and purity can vary between brands and batches.

Psilocybin in clinical research: what trials have shown

Psilocybin — the active compound in certain mushroom species — has been studied in controlled clinical trials for specific mental health conditions. A landmark 2020 trial published in JAMA Psychiatry found that a single dose of psilocybin, given alongside psychological support, reduced depression symptoms in people with treatment-resistant depression (depression that had not responded to at least two antidepressants). Participants showed improvement within one to two weeks, and about half maintained that improvement at the four-week follow-up.

Research on psilocybin for end-of-life anxiety has also produced measurable results. Studies at Johns Hopkins and New York University found that a single guided psilocybin session reduced anxiety and depression in people with terminal cancer diagnoses. These effects persisted for months in many participants. The mechanism appears to involve changes in how the brain processes threat and meaning, not straightforward sedation or distraction.

However, these trials were small — typically 20 to 80 participants — and conducted in specialized research settings with trained facilitators present. The FDA has designated psilocybin-assisted therapy as a "breakthrough therapy" for treatment-resistant depression, which speeds up the review process, but approval is not yet granted. Psilocybin remains a Schedule I controlled substance in the United States, meaning it is illegal to possess outside of approved research.

Medicinal mushrooms: lion's mane, reishi, and cordyceps

Lion's mane is a white, shaggy mushroom that has been used in Asian medicine for centuries. Laboratory and animal studies suggest it may stimulate nerve growth factor (NGF), a protein involved in brain cell growth and repair. A 2019 human trial in Phytotherapy Research found that older adults who took lion's mane extract for 16 weeks showed modest improvements on cognitive tests compared to placebo. However, the study involved only 30 participants, and the effect size was small. More research in larger groups is needed before claims about memory or cognitive decline can be considered established.

Reishi is a woody fungus traditionally used to promote sleep and reduce stress. Animal studies show it contains compounds that may interact with the nervous system, but human trials are limited. A 2012 review in Journal of Ethnopharmacology found that reishi showed some promise for anxiety and sleep in small studies, but the quality of evidence was low — many trials were short, had few participants, or lacked proper control groups. It is not clear whether reishi is more effective than placebo for these purposes in humans.

Cordyceps are parasitic fungi traditionally used to boost energy and athletic performance. A few small human studies suggest cordyceps may improve oxygen utilization during exercise, but the evidence is mixed and the studies are often poorly designed. Claims about cordyceps improving stamina or sexual function remain largely unsupported by rigorous human research.

How medicinal mushroom compounds work (and what we don't know)

Medicinal mushrooms contain hundreds of compounds — polysaccharides, beta-glucans, ergothioneine, and others — that can affect immune function, inflammation, and cell signaling in laboratory settings. This is why they show activity in test tubes and in animals. The gap between "active in a petri dish" and "produces a measurable health effect in a person" is large, however, and most medicinal mushrooms have not been tested in large, well-controlled human trials.

The challenge is that mushroom extracts are complex mixtures, not single molecules. Different extraction methods (water, alcohol, hot water) pull out different compounds, so two "lion's mane" products may contain very different active ingredients. This makes it hard to know what dose actually matters or whether the effect in one study will show up in another using a different extract.

Psilocybin versus medicinal mushrooms: the evidence gap

Psilocybin research and medicinal mushroom research operate in different worlds. Psilocybin trials are conducted under FDA oversight, with standardized doses, trained facilitators, and careful measurement of outcomes. They are small but rigorous. Medicinal mushroom research often comes from traditional medicine systems or is conducted in countries with different regulatory standards, and many studies are small, short, or lack proper control groups.

This does not mean medicinal mushrooms are ineffective — it means the evidence is not yet at the level required to call them proven treatments. Some compounds show genuine promise and warrant larger trials. Others remain largely unexplored in humans. Psilocybin, by contrast, has shown real effects in controlled settings, but legal barriers and the need for professional supervision mean it is not yet available as a standard treatment outside of research.

Mushroom supplements: quality, regulation, and what to know

Medicinal mushroom supplements sold over the counter are not regulated by the FDA the way pharmaceuticals are. The FDA does not verify that the label accurately describes what is in the bottle, that the dose is consistent from batch to batch, or that the product is free of contaminants. Third-party testing by organizations like NSF International or USP can provide some assurance, but it is not required.

Mushroom supplements may contain the whole fruiting body, mycelium (the root-like structure), or an extract. Different forms have different potencies and compositions. A product labeled "lion's mane" might be a water extract, an alcohol extract, or a dried powder, and these will have different effects. There is no standard dose for most medicinal mushrooms, so recommendations vary widely.

If you are considering a mushroom supplement, look for products that have been tested by a third party, that clearly state what part of the mushroom is used and how it was extracted, and that list the amount of active compounds (like beta-glucans) rather than just the total weight. Talk to a doctor or pharmacist before starting, especially if you take other medications — some mushroom compounds can interact with blood thinners or immunosuppressants.

Current research directions and what remains unclear

Psilocybin research is moving toward FDA approval pathways for treatment-resistant depression and possibly other conditions. Several companies are running Phase 3 trials (the final stage before approval consideration), and results are expected over the next few years. The main open questions are whether the effects hold up in larger, more diverse populations, whether the treatment works without the psychological support component, and what the long-term safety profile looks like.

For medicinal mushrooms, the research agenda is less clear. Some compounds (like beta-glucans from certain mushroom species) have enough evidence to warrant larger human trials. Others remain in the early stages. The biggest barrier is funding — medicinal mushrooms cannot be patented in the same way as synthetic drugs, so pharmaceutical companies have less financial incentive to run expensive trials. Much of the research that does happen is funded by mushroom growers or supplement companies, which can introduce bias.

Frequently Asked Questions

Can I legally use psilocybin mushrooms for depression right now?

Not in most places. Psilocybin is a Schedule I controlled substance in the United States and illegal to possess outside of FDA-approved research trials. Some cities (like Denver and Oakland) have decriminalized psilocybin, meaning possession is a low priority for law enforcement, but it is not legal. A few clinical trials are still enrolling participants; you can search ClinicalTrials.gov to see if there is a trial near you.

Are medicinal mushroom supplements safe?

Most medicinal mushrooms are generally well-tolerated in the short term, but long-term safety data in humans is limited. Some people report digestive upset, allergic reactions, or interactions with medications like blood thinners. If you have a mushroom allergy, autoimmune disease, or take medications, talk to a doctor before starting a supplement.

Do medicinal mushrooms actually work, or is it just placebo?

Some show activity in lab and animal studies, but the human evidence is weak for most. Lion's mane has the most promising human data so far, though the studies are still small. For others like reishi, we do not yet know whether the effect is real or placebo. More research is needed.

What is the difference between psilocybin mushrooms and medicinal mushrooms?

Psilocybin mushrooms contain psychoactive compounds that alter perception and mood; they are used in research for mental health conditions. Medicinal mushrooms (lion's mane, reishi, cordyceps) do not cause hallucinations; they are used for general health and have been part of traditional medicine for centuries. The research standards and evidence quality differ significantly between the two.

Can I grow medicinal mushrooms at home and use them?

Yes, growing culinary or medicinal mushroom species is legal in most places. However, if you grow them yourself, you will not know the potency or whether they contain contaminants. Store-bought supplements from reputable brands are more consistent, though still not regulated as strictly as pharmaceuticals.